Tyrosine kinase inhibitor treatment outcome in a single center cohort of chronic myeloid leukemia patients. The role of the T315I ABL kinase domain mutation
, , , , , oraz
08 sie 2013
O artykule
Data publikacji: 08 sie 2013
Zakres stron: 29 - 37
DOI: https://doi.org/10.2478/rrlm-2013-0015
Słowa kluczowe
This content is open access.
Dima, Delia
Trifa, Adrian P.
Paţiu, Mariana
Vesa, Cristian S.
Frinc, Ioana C.
Petrov, Ljubomir
Cucuianu, Andrei